Vitiligo is caused by the immune system attacking and destroying melanocytes, the cells that produce skin pigment. It affects between 0.5% and 2% of the global population, and about half of people with vitiligo develop the condition before age 20. While the immune attack is the direct cause of pigment loss, the reasons that attack begins in the first place involve a mix of genetic vulnerability, oxidative stress, chemical exposures, and psychological triggers.
How the Immune System Destroys Pigment Cells
The white patches of vitiligo appear because a specific type of immune cell, called a cytotoxic T-cell, mistakes melanocytes for a threat and kills them. These T-cells normally patrol the body looking for infected or damaged cells. In vitiligo, they become “autoreactive,” meaning they lock onto healthy melanocytes instead.
Once these rogue T-cells find melanocytes in the skin, they release signaling molecules that attract even more T-cells to the area. This creates a self-reinforcing cycle: the initial attack draws reinforcements, which destroy more melanocytes, which exposes more cellular debris that the immune system interprets as a threat. The result is an expanding patch of skin that has completely lost its ability to produce pigment. This is why vitiligo patches often grow outward from where they first appeared rather than popping up randomly all at once.
Genetic Factors That Set the Stage
Vitiligo runs in families, though it doesn’t follow a simple inheritance pattern. Genome-wide studies have identified around 50 different genetic locations linked to vitiligo risk. Roughly 85% of those genes control immune system function and a process called apoptosis, which is how the body disposes of damaged cells. In other words, most of the genetic risk for vitiligo comes from inheriting an immune system that’s slightly more prone to misfiring.
A few specific genes stand out. One, called PTPN22, encodes a protein that acts as a brake on immune cell activation. Certain variants of this gene are more common in people with vitiligo and also show up at higher rates in people with type 1 diabetes, rheumatoid arthritis, and lupus. Another gene, NLRP1, helps regulate inflammation; particular versions of it predispose people to vitiligo and other autoimmune conditions. A third gene, TYR, encodes tyrosinase, the main enzyme melanocytes use to produce pigment. Because the immune system in vitiligo specifically targets melanocytes, the version of tyrosinase a person carries may determine how “visible” their melanocytes are to those autoreactive T-cells.
Having these gene variants doesn’t guarantee vitiligo will develop. Most people who carry them never lose pigment. But the variants lower the threshold, making it easier for an environmental trigger to set the autoimmune process in motion.
Oxidative Stress and Melanocyte Damage
Before the immune system ever gets involved, something has to put melanocytes under enough stress that they start looking abnormal. Oxidative stress is a leading candidate. Melanocytes in people with vitiligo show defective mitochondria, the energy-producing structures inside every cell. These damaged mitochondria leak reactive oxygen species (ROS), which are unstable molecules that harm cell membranes, proteins, and DNA.
When ROS accumulate beyond what the cell’s natural antioxidant defenses can handle, the melanocyte begins to break down. It may die through several different pathways, releasing fragments of itself into the surrounding tissue. The immune system detects those fragments as foreign, and the autoimmune cycle begins. This is why oxidative stress is often described as the “match” that lights the autoimmune “fire.” The melanocytes were already vulnerable because of their genetics, and the oxidative damage is what finally draws immune attention to them.
Chemical and Environmental Triggers
Certain chemicals can directly damage melanocytes and trigger vitiligo in people who are genetically susceptible. Phenol and catechol derivatives are the most well-documented culprits. These compounds are found in a surprisingly wide range of everyday products: hair dyes, detergents, cleansers, rubber footwear, insecticides, deodorants, and even some colored toothpastes. Hydroquinone, a common ingredient in skin-lightening creams, has also been linked to chemical-induced pigment loss.
Occupational exposure matters too. Workers who regularly handle phenol or catechol-based chemicals face roughly four times the risk of developing vitiligo compared to people without that exposure. Living near a polluting industrial site triples the risk. Even routine household chemical use has been associated with a threefold increase. These chemicals appear to work by triggering melanocyte death directly, which then feeds into the same immune-mediated destruction seen in all forms of vitiligo.
Physical trauma to the skin is another environmental trigger. The Koebner phenomenon describes the development of new vitiligo patches at sites of injury, such as cuts, burns, or even friction from tight clothing. Studies suggest this occurs in the majority of people with active vitiligo. The injury likely damages melanocytes locally, exposing their contents to the immune system and seeding new patches in previously unaffected skin.
Psychological Stress as a Trigger
Stressful life events, including the death of a family member, job loss, or financial hardship, are frequently reported in the months before vitiligo first appears. This isn’t just anecdotal. In controlled studies, vitiligo patients scored significantly higher on perceived stress scales than matched controls (average scores of 19.3 versus 13.8 on a standard stress questionnaire). Female patients reported even higher stress levels than male patients.
The biological link is plausible. Stress elevates cortisol, catecholamines, and neuropeptides, all of which are found at higher levels in people with vitiligo. These stress hormones can shift immune function toward a more inflammatory state, potentially tipping a genetically susceptible person into active autoimmunity. Medical records analysis has found signs of metabolic stress appearing before a vitiligo diagnosis, suggesting the stress isn’t just a consequence of having the condition. Stressful events appear to be a more common precipitating factor in adult-onset vitiligo than in childhood cases.
Connection to Other Autoimmune Conditions
Vitiligo rarely exists in isolation. The most common companion condition is autoimmune thyroid disease, including both Hashimoto’s thyroiditis and Graves’ disease. This association has been documented in dozens of studies over several decades and is strong enough that many dermatologists screen vitiligo patients for thyroid problems as a matter of routine.
Beyond thyroid disease, vitiligo appears more frequently in people and families affected by type 1 diabetes, rheumatoid arthritis, pernicious anemia, systemic lupus erythematosus, psoriasis, and inflammatory bowel disease. This clustering isn’t coincidental. Many of these conditions share the same susceptibility genes, particularly PTPN22 and NLRP1. Having one autoimmune condition doesn’t cause another, but the underlying genetic wiring that makes the immune system more reactive increases the odds of developing more than one.
Two Types With Different Patterns
Not all vitiligo behaves the same way. Non-segmental vitiligo, the more common form, typically appears symmetrically on both sides of the body and is strongly tied to autoimmune markers, including detectable antibodies against melanocytes. It tends to progress over time, and body hair in affected areas usually stays pigmented at first, though it may lose color as the disease advances.
Segmental vitiligo affects only one side or one segment of the body and is less clearly linked to autoimmune markers. It tends to stabilize faster than non-segmental vitiligo and responds well to melanocyte transplant procedures. The distinction matters because the underlying drivers may differ: non-segmental vitiligo appears to be a systemic autoimmune process, while segmental vitiligo may involve more localized factors, possibly related to nerve signaling in a specific skin region. A neural hypothesis proposes that nerve endings in the skin release substances toxic to nearby melanocytes, which could explain why segmental vitiligo follows nerve distribution patterns rather than spreading symmetrically.